Targeting the Androgen Receptor in Prostate Cancer - A Resilient Foe

被引：34
作者：
Nelson, Peter S. [1 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2014年 / 371卷 / 11期
关键词：
INCREASED SURVIVAL; SPLICE VARIANTS; CASTRATION; ENZALUTAMIDE; ABIRATERONE;
D O I：
10.1056/NEJMe1409306
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1067 / 1069
页数：3
相关论文
共 10 条
  • [1] AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
    Antonarakis, Emmanuel S.
    Lu, Changxue
    Wang, Hao
    Luber, Brandon
    Nakazawa, Mary
    Roeser, Jeffrey C.
    Chen, Yan
    Mohammad, Tabrez A.
    Chen, Yidong
    Fedor, Helen L.
    Lotan, Tamara L.
    Zheng, Qizhi
    De Marzo, Angelo M.
    Isaacs, John T.
    Isaacs, William B.
    Nadal, Rosa
    Paller, Channing J.
    Denmeade, Samuel R.
    Carducci, Michael A.
    Eisenberger, Mario A.
    Luo, Jun
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11) : 1028 - 1038
  • [2] Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone
    Bianchini, D.
    Lorente, D.
    Rodriguez-Vida, A.
    Omlin, A.
    Pezaro, C.
    Ferraldeschi, R.
    Zivi, A.
    Attard, G.
    Chowdhury, S.
    de Bono, J. S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 (01) : 78 - 84
  • [3] Molecular determinants of resistance to antiandrogen therapy
    Chen, CD
    Welsbie, DS
    Tran, C
    Baek, SH
    Chen, R
    Vessella, R
    Rosenfeld, MG
    Sawyers, CL
    [J]. NATURE MEDICINE, 2004, 10 (01) : 33 - 39
  • [4] Abiraterone and Increased Survival in Metastatic Prostate Cancer
    De Bono, Johann S.
    Logothetis, Christopher J.
    Molina, Arturo
    Fizazi, Karim
    North, Scott
    Chu, Luis
    Chi, Kim N.
    Jones, Robert J.
    Goodman, Oscar B., Jr.
    Saad, Fred
    Staffurth, John N.
    Mainwaring, Paul
    Harland, Stephen
    Flaig, Thomas W.
    Hutson, Thomas E.
    Cheng, Tina
    Patterson, Helen
    Hainsworth, John D.
    Ryan, Charles J.
    Sternberg, Cora N.
    Ellard, Susan L.
    Flechon, Aude
    Saleh, Mansoor
    Scholz, Mark
    Efstathiou, Eleni
    Zivi, Andrea
    Bianchini, Diletta
    Loriot, Yohann
    Chieffo, Nicole
    Thian Kheoh
    Haqq, Christopher M.
    Scher, Howard I.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (21) : 1995 - 2005
  • [5] Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
    Hu, Rong
    Lu, Changxue
    Mostaghel, Elahe A.
    Yegnasubramanian, Srinivasan
    Gurel, Meltem
    Tannahill, Clare
    Edwards, Joanne
    Isaacs, William B.
    Nelson, Peter S.
    Bluemn, Eric
    Plymate, Stephen R.
    Luo, Jun
    [J]. CANCER RESEARCH, 2012, 72 (14) : 3457 - 3462
  • [6] Huggins C, 1941, CANCER RES, V1, P293
  • [7] Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth
    Montgomery, R. Bruce
    Mostaghel, Elahe A.
    Vessella, Robert
    Hess, David L.
    Kalhorn, Thomas F.
    Higano, Celestia S.
    True, Lawrence D.
    Nelson, Peter S.
    [J]. CANCER RESEARCH, 2008, 68 (11) : 4447 - 4454
  • [8] Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
    Scher, Howard I.
    Fizazi, Karim
    Saad, Fred
    Taplin, Mary-Ellen
    Sternberg, Cora N.
    Miller, Kurt
    de Wit, Ronald
    Mulders, Peter
    Chi, Kim N.
    Shore, Neal D.
    Armstrong, Andrew J.
    Flaig, Thomas W.
    Flechon, Aude
    Mainwaring, Paul
    Fleming, Mark
    Hainsworth, John D.
    Hirmand, Mohammad
    Selby, Bryan
    Seely, Lynn
    de Bono, Johann S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (13) : 1187 - 1197
  • [9] Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer
    Ware, Kathryn E.
    Garcia-Blanco, Mariano A.
    Armstrong, Andrew J.
    Dehm, Scott M.
    [J]. ENDOCRINE-RELATED CANCER, 2014, 21 (04) : T87 - T103
  • [10] Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
    Watson, Philip A.
    Chen, Yinan F.
    Balbas, Minna D.
    Wongvipat, John
    Socci, Nicholas D.
    Viale, Agnes
    Kim, Kwanghee
    Sawyers, Charles L.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (39) : 16759 - 16765
1